SI0941100T1 - Pharmaceutical compositions containing lamivudine and zidovudine - Google Patents
Pharmaceutical compositions containing lamivudine and zidovudineInfo
- Publication number
- SI0941100T1 SI0941100T1 SI9730570T SI9730570T SI0941100T1 SI 0941100 T1 SI0941100 T1 SI 0941100T1 SI 9730570 T SI9730570 T SI 9730570T SI 9730570 T SI9730570 T SI 9730570T SI 0941100 T1 SI0941100 T1 SI 0941100T1
- Authority
- SI
- Slovenia
- Prior art keywords
- zidovudine
- pharmaceutical compositions
- compositions containing
- containing lamivudine
- lamivudine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9622681.6A GB9622681D0 (en) | 1996-10-31 | 1996-10-31 | Pharmaceutical compositions |
| EP97950036A EP0941100B1 (en) | 1996-10-31 | 1997-10-29 | Pharmaceutical compositions containing lamivudine and zidovudine |
| PCT/EP1997/005953 WO1998018477A2 (en) | 1996-10-31 | 1997-10-29 | Pharmaceutical compositions containing lamivudine and zidovudine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0941100T1 true SI0941100T1 (en) | 2003-12-31 |
Family
ID=10802224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9730570T SI0941100T1 (en) | 1996-10-31 | 1997-10-29 | Pharmaceutical compositions containing lamivudine and zidovudine |
Country Status (44)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
| GB9809213D0 (en) * | 1998-04-29 | 1998-07-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| DE60219965T2 (de) * | 2002-04-23 | 2008-01-17 | Lupin Ltd., Mumbai | Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine |
| DE60313657T2 (de) * | 2002-11-08 | 2008-01-03 | Smithkline Beecham Corp. | Antivirale zusammensetzungen |
| AU2004206827A1 (en) | 2003-01-14 | 2004-08-05 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
| AR045841A1 (es) * | 2004-09-28 | 2005-11-16 | Richmond Sa Com Ind Y Financie | Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla. |
| WO2011156594A2 (en) | 2010-06-09 | 2011-12-15 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment |
| CN104203244A (zh) | 2012-03-05 | 2014-12-10 | 希普拉有限公司 | 包含拉米夫定、festinnvir和奈韦拉平的抗反转录病毒药物组合物 |
| WO2014130553A2 (en) * | 2013-02-20 | 2014-08-28 | Abbvie Inc. | Tablet dosage forms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4950652A (en) * | 1987-03-23 | 1990-08-21 | Hem Research, Inc. | dsRNAs for combination therapy in the treatment of viral diseases |
| WO1992020344A1 (en) * | 1991-05-16 | 1992-11-26 | Glaxo Group Limited | Antiviral combinations containing nucleoside analogs |
| GB9110624D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Combinations |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1996
- 1996-10-31 GB GBGB9622681.6A patent/GB9622681D0/en active Pending
-
1997
- 1997-10-24 HR HR970569A patent/HRP970569B1/xx not_active IP Right Cessation
- 1997-10-28 SV SV1997000090A patent/SV1997000090A/es not_active Application Discontinuation
- 1997-10-28 MY MYPI97005103A patent/MY119513A/en unknown
- 1997-10-28 CO CO97063174A patent/CO4930269A1/es unknown
- 1997-10-29 PE PE1997000965A patent/PE10099A1/es not_active Application Discontinuation
- 1997-10-29 DK DK97950036T patent/DK0941100T3/da active
- 1997-10-29 WO PCT/EP1997/005953 patent/WO1998018477A2/en active IP Right Grant
- 1997-10-29 NZ NZ335153A patent/NZ335153A/en unknown
- 1997-10-29 EA EA199900345A patent/EA002437B1/ru not_active IP Right Cessation
- 1997-10-29 GT GT199700116A patent/GT199700116A/es unknown
- 1997-10-29 JP JP10520045A patent/JP2001502718A/ja active Pending
- 1997-10-29 AU AU53142/98A patent/AU736607B2/en not_active Ceased
- 1997-10-29 BR BR9712614-4A patent/BR9712614A/pt not_active IP Right Cessation
- 1997-10-29 UA UA99042239A patent/UA64725C2/uk unknown
- 1997-10-29 AP APAP/P/1999/001519A patent/AP1067A/en active
- 1997-10-29 EE EEP199900175A patent/EE03806B1/xx not_active IP Right Cessation
- 1997-10-29 HU HU0000344A patent/HU224969B1/hu not_active IP Right Cessation
- 1997-10-29 ZA ZA979726A patent/ZA979726B/xx unknown
- 1997-10-29 CZ CZ0155799A patent/CZ296080B6/cs not_active IP Right Cessation
- 1997-10-29 ES ES97950036T patent/ES2200204T3/es not_active Expired - Lifetime
- 1997-10-29 EP EP97950036A patent/EP0941100B1/en not_active Expired - Lifetime
- 1997-10-29 AT AT97950036T patent/ATE241364T1/de active
- 1997-10-29 IL IL12942297A patent/IL129422A0/xx not_active IP Right Cessation
- 1997-10-29 PT PT97950036T patent/PT941100E/pt unknown
- 1997-10-29 SI SI9730570T patent/SI0941100T1/xx unknown
- 1997-10-29 SK SK575-99A patent/SK284286B6/sk unknown
- 1997-10-29 DE DE69722433T patent/DE69722433T2/de not_active Expired - Lifetime
- 1997-10-29 YU YU19999A patent/YU19999A/sh unknown
- 1997-10-29 TR TR1999/00950T patent/TR199900950T2/xx unknown
- 1997-10-29 PL PL97333143A patent/PL190349B1/pl unknown
- 1997-10-29 AR ARP970105027A patent/AR009135A1/es unknown
- 1997-10-29 GE GEAP19974781A patent/GEP20022735B/en unknown
- 1997-10-29 CA CA002270174A patent/CA2270174A1/en not_active Abandoned
- 1997-10-29 KR KR1019997003757A patent/KR100551652B1/ko not_active IP Right Cessation
- 1997-10-30 UY UY24766A patent/UY24766A1/es not_active IP Right Cessation
- 1997-10-30 ID IDP973554A patent/ID18698A/id unknown
- 1997-10-30 PA PA19978441101A patent/PA8441101A1/es unknown
-
1999
- 1999-04-09 IS IS5024A patent/IS5024A/is unknown
- 1999-04-23 OA OA9900088A patent/OA11038A/en unknown
- 1999-04-29 NO NO19992091A patent/NO317163B1/no unknown
- 1999-05-26 BG BG103435A patent/BG64541B1/bg unknown
- 1999-12-24 HK HK99106129A patent/HK1020880A1/xx not_active IP Right Cessation
-
2004
- 2004-11-26 CY CY0400085A patent/CY2485B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
| IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
| IL191904A0 (en) | Pharmaceutical and compositions containing a?? fragments | |
| HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
| HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
| PL336840A1 (en) | Hair-care composition | |
| PL335870A1 (en) | Hair-care composition | |
| IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP9900424A2 (hu) | Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP9901452A3 (en) | Bicyclic-aromatic compounds and pharmaceutical compositions containing them | |
| IL128058A0 (en) | Illudin analogs and pharmaceutical compositions containing the same | |
| PL331423A1 (en) | Muporocin and chlorohexidrin containing compositions | |
| IL117623A (en) | Maltitol composition and its preparation | |
| HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
| IL133928A0 (en) | Pharmaceutical composition containing peptichemio | |
| EP0968983A4 (en) | COMPOSITION BASED ON HEXANITROHEXAAZAISOWURTIZITAN AND HEXANITROHEXAAZAISOWURTIZITAN COMPOSITION OF EXPLOSIVES | |
| HUP0000344A3 (en) | Pharmaceutical compositions containing lamivudine and zidovudine | |
| IL131917A (en) | Pharmaceutical compositions containing lamivudine | |
| HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
| IL112564A0 (en) | 1-beta-methyl-carbapenems and compositions containing them | |
| GB9623962D0 (en) | Pharmaceutical composition | |
| IL115882A0 (en) | Oxazolyl-and thiazolylimidazo-benzo-and thienodiazepines their manufacture and pharmaceutical compositions containing them | |
| HUP0000275A3 (en) | Phenanethridinium derivatives and pharmaceutical compositions containing them | |
| HUP9901968A3 (en) | 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them | |
| HUP0003528A3 (en) | Pharmaceutical compositions containing dihydropolyprenols |